Literature DB >> 10732762

Activity of growth factors in the IL-6 group in the differentiation of human lung adenocarcinoma.

C McCormick1, R I Freshney.   

Abstract

The role of the interleukin-6 (IL-6) group of cytokines in differentiation of two lung adenocarcinoma cell lines has been examined using induction of alkaline phosphatase and expression of surfactant protein A. Oncostatin M was the most active and potent for alkaline phosphatase in A549 cells, with IL-6 having similar activity but less potency. Neither cytokine induced alkaline phosphatase in NCI-H441 cells, although induction was obtained with lung fibroblast-conditioned medium. Surfactant protein A was induced in NCI-H441 cells by conditioned medium and dexamethasone and, to a much lesser extent, by oncostatin M or IL-6. Induction of alkaline phosphatase and surfactant protein A were both dexamethasone-dependent, though some induction of surfactant protein A was obtained with interferon-alpha in the absence of dexamethasone. The activity present in lung fibroblast-conditioned medium suggests paracrine control, but this appears not to be due to oncostatin M or IL-6 as disabling antibodies to either cytokine were not inhibitory, and, although alkaline phosphatase was induced in A549 by both cytokines, it was only induced by conditioned medium in NCI-H441 cells. Furthermore, surfactant protein A was induced in H441 by conditioned medium to a much greater extent than by oncostatin M or IL-6. These data demonstrate that cytokines of the IL-6 group have potential as differentiation inducers in lung adenocarcinoma cells and that there is an equivalent paracrine factor(s) in lung fibroblast conditioned medium. As the production of this factor by fibroblasts is not enhanced by glucocorticoid, although the response of the target cell is, it would appear to be distinct from the fibrocyte pneumocyte factor previously described by Post et al 1984.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10732762      PMCID: PMC2374402          DOI: 10.1054/bjoc.1999.1015

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  48 in total

1.  Glucocorticoid block of protein kinase C signalling in mouse pituitary corticotroph AtT20 D16:16 cells.

Authors:  L Tian; J A Philp; M J Shipston
Journal:  J Physiol       Date:  1999-05-01       Impact factor: 5.182

2.  Glucocorticoids induce Kaposi's sarcoma cell proliferation through the regulation of transforming growth factor-beta.

Authors:  J Cai; T Zheng; M Lotz; Y Zhang; R Masood; P Gill
Journal:  Blood       Date:  1997-03-01       Impact factor: 22.113

3.  The glucocorticoid-glucocorticoid receptor signal transduction pathway, transforming growth factor-beta, and embryonic mouse lung development in vivo.

Authors:  T Jaskoll; H A Choy; M Melnick
Journal:  Pediatr Res       Date:  1996-05       Impact factor: 3.756

Review 4.  Gp130 and the interleukin-6 family of cytokines.

Authors:  T Taga; T Kishimoto
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

Review 5.  Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors?

Authors:  J Schlessinger; I Lax; M Lemmon
Journal:  Cell       Date:  1995-11-03       Impact factor: 41.582

Review 6.  Cell cycle regulatory proteins are targets for induced differentiation of transformed cells: Molecular and clinical studies employing hybrid polar compounds.

Authors:  P A Marks; V M Richon; R A Rifkind
Journal:  Int J Hematol       Date:  1996-01       Impact factor: 2.490

7.  Glucocorticoids inhibit oncostatin M-induced phospholipase A2 gene expression in human hepatoma cells.

Authors:  J Haselmann; M Goppelt-Struebe
Journal:  Cytokine       Date:  1997-03       Impact factor: 3.861

8.  Keratinocyte growth factor and embryonic rat lung morphogenesis.

Authors:  M Shiratori; E Oshika; L P Ung; G Singh; H Shinozuka; D Warburton; G Michalopoulos; S L Katyal
Journal:  Am J Respir Cell Mol Biol       Date:  1996-09       Impact factor: 6.914

9.  Activation of paracrine growth factors by heparan sulphate induced by glucocorticoid in A549 lung carcinoma cells.

Authors:  N Yevdokimova; R I Freshney
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Leukemia inhibitory factor-dependent transcriptional activation in embryonic stem cells.

Authors:  H Boeuf; C Hauss; F D Graeve; N Baran; C Kedinger
Journal:  J Cell Biol       Date:  1997-09-22       Impact factor: 10.539

View more
  1 in total

Review 1.  The enigmatic cytokine oncostatin m and roles in disease.

Authors:  Carl D Richards
Journal:  ISRN Inflamm       Date:  2013-12-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.